ClinicalTrials.gg
RecruitingNCT06978816Updated Mar 18, 2026

Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief

An interventional study of Non-Steroidal anti-inflammatory drugs (NSAIDS) and Auricular Acupoint Embedding in Renal Colic and Acupuncture, Ear, sponsored by Gao Xiaofeng. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by Gao Xiaofeng · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Title: Can Ear Acupressure Help Relieve Kidney Stone Pain Faster When Combined with Painkillers?

Purpose:

This study tests whether adding ear acupressure to standard painkillers (NSAIDs) helps adults with kidney stone pain feel better faster. The investigators also want to know if this combination causes any side effects.

Key Questions:

Does ear acupressure + NSAIDs reduce pain more quickly than NSAIDs alone? Are there any safety concerns with this treatment? How does real ear acupressure compare to a fake (placebo) procedure? Who Can Join? Adults aged 18-75 Experiencing moderate-to-severe kidney stone pain (confirmed by CT or ultrasound) No recent painkiller use or allergies to NSAIDs

What Participants Will Do:

Receive in the emergency room:

Real treatment: Tiny needles placed on 3 ear points + NSAIDs (ketorolac injection) OR Placebo treatment: Fake tape on ear points + NSAIDs (same injection) Rate their pain on a 0-10 scale over 60 minutes. Have their heart rate and blood pressure checked.

Study Details:

Duration: Single ER visit (no long-term follow-up) Participants Needed: 116 Safety: Rescue pain medication (like morphine) is available if needed.

Why This Matters:

Kidney stones cause severe pain, and current painkillers may not work fast enough. Ear acupressure is a low-risk method from traditional Chinese medicine that could provide quicker relief.

Ethics:

Approved by Changhai Hospital's Ethics Committee. Participants can leave the study anytime.

02

Conditions studied

  • Renal Colic
  • Acupuncture, Ear

Keywords

  • Kidney Calculi
  • Renal Colic
  • acupuncture, ear
03

In context

Renal Colic

79 studies on the registry are indexed under Renal Colic; 10 are open to participants now.

This study's planned enrollment of 116 is close to the median of 118 across 60 interventional studies indexed under Renal Colic.

Browse Renal Colic studies →

Lead sponsor

This is the only study on the registry with Gao Xiaofeng as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age between 15 and 75 years (inclusive)
  2. Diagnosis of urinary tract stones confirmed by CT or ultrasound
  3. Visual Analog Scale (VAS) score ≥ 4 (indicating moderate to severe renal colic)
  4. No severe cardiac, hepatic, or pulmonary dysfunction, and no coagulation disorders.
  5. No psychiatric disorders

Exclusion criteria

Exclusion Criteria:

  1. Use of any analgesic medication within the past 6 hours.
  2. Allergy to NSAIDs, morphine, or anisodamine (scopolamine derivatives)
  3. History of asthma, urticaria, congestive heart failure, acute ischemic heart disease, acute cerebrovascular disease, or increased intracranial pressure
  4. Active peptic ulcer, pyloric obstruction, or intestinal obstruction
  5. Severe adverse reactions to acupuncture in the past
  6. Pregnancy or lactation
  7. Unwillingness to sign
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
116 participants (estimated)

Study arms

  • Experimental
    Verum Auricular Acupoint Embedding Group

    In the experimental group, patients received verum auricular acupoint embedding using disposable sterile press needles (0.22×0.5 mm) at three ipsilateral ear points - thalamus (MA-AT), kidney (MA-SC), and shenmen (MA-TF1) - combined with intravenous infusion of 50 mg dexketoprofen trometamol (a non-steroidal anti-inflammatory drug) as adjuvant therapy.

    Drug: Non-Steroidal anti-inflammatory drugs (NSAIDS) · Other: Auricular Acupoint Embedding

  • Sham comparator
    Sham Auricular Acupoint Embedding Group

    In the control group, participants received sham auricular stimulation using non-penetrating adhesive patches applied to the same ipsilateral ear points (thalamus \[MA-AT\], kidney \[MA-SC\], and shenmen \[MA-TF1\]) without needle insertion, combined with identical intravenous administration of 50 mg dexketoprofen trometamol (NSAID) as per the experimental protocol

    Drug: Non-Steroidal anti-inflammatory drugs (NSAIDS) · Other: Sham Acupoint Embedding

Interventions

  • Intravenous infusion of 50 mg dexketoprofen trometamol injection

  • OtherAuricular Acupoint Embedding

    Concurrently with the intravenous infusion of dexketoprofen trometamol, verum auricular acupoint embedding was performed using disposable sterile press needles at three ipsilateral ear points: thalamus (MA-AT), kidney (MA-SC), and shenmen (MA-TF1), with needle retention for 60 minutes

    Also known as: acupuncture, ear

  • OtherSham Acupoint Embedding

    Concurrently with the intravenous infusion of dexketoprofen trometamol, sham auricular stimulation was administered using non-penetrating adhesive patches applied to three ipsilateral ear points: thalamus (MA-AT), kidney (MA-SC), and shenmen (MA-TF1), maintaining the application for 60 minutes.

06

What researchers measure

Primary outcomes

  1. Response rate of Visual Analog Scale (VAS) reduction

    The Visual Analog Scale (VAS) is a validated, subjective measurement tool widely used in clinical research to assess symptom intensity (e.g., pain, nausea). It consists of a 100-mm horizontal or vertical line anchored by two extremes: "no symptom" (0 mm) and "worst imaginable symptom" (100 mm). Participants mark their current level of intensity, with the score determined by measuring the distance from the "no symptom" endpoint.Response rate of Visual Analog Scale (VAS) reduction (defined as ≥50% decrease from baseline)

    Time frame: At 0, 5, 10, 15, 20, 30, 45, and 60 minutes after intervention initiation

Secondary outcomes

  1. Recurrence rate of pain within 48 hours

    "Recurrence" is defined as revisiting the emergency department due to renal colic.

    Time frame: Within 48 hours after the completion of this emergency treatment

  2. Incidence of adverse reactions

    Adverse reactions refer to harmful effects caused by medical treatment, such as: nausea, rash, dizziness, abnormal liver function, etc.

    Time frame: At 0, 5, 10, 15, 20, 30, 45, and 60 minutes after intervention initiation

  3. body temperature

    Body temperature refers to the internal temperature of the human body and is a key indicator for maintaining normal physiological functions and metabolic activities. It is typically measured in degrees Celsius (°C) or Fahrenheit (°F), and its stable range is precisely regulated by the hypothalamus (the body's thermoregulatory center).

    Time frame: At 0, 5, 10, 15, 20, 30, 45, and 60 minutes after intervention initiation

  4. Blood pressure

    Blood pressure refers to the force exerted by circulating blood against the walls of blood vessels, primarily the arteries. It is conventionally measured in mmHg. It is a vital physiological parameter that ensures adequate blood flow to organs and tissues.

    Time frame: At 0, 5, 10, 15, 20, 30, 45, and 60 minutes after intervention initiation

  5. Heart rate

    Heart rate refers to the number of heartbeats per minute (bpm), reflecting the cardiac cycle frequency. It is a vital cardiovascular parameter indicating circulatory system function.

    Time frame: At 0, 5, 10, 15, 20, 30, 45, and 60 minutes after intervention initiation

07

Study locations

1 of 1 sites recruiting
  • shanghai Changhai Hospitai
    Shanghai, Shanghai Municipality 200433, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06978816
Lead sponsor
Gao Xiaofeng
Responsible party
Gao Xiaofeng (Senior Attending Urologist, Changhai Hospital, Changhai Hospital) — Sponsor-investigator
First posted
May 18, 2025
Start date
Jun 1, 2025
Primary completion
Jun 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Mar 18, 2026

Study contacts

Bowen Yu, bachelor
Contact
yubowen19960609@qq.com
+8613125430609 ext. +8613817275828

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion